Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
City of Hope Medical Center
City of Hope Medical Center
Medical College of Wisconsin
Dartmouth-Hitchcock Medical Center
Second Xiangya Hospital of Central South University
H. Lee Moffitt Cancer Center and Research Institute
MedSIR
University of Oklahoma
UNC Lineberger Comprehensive Cancer Center
PETHEMA Foundation
M.D. Anderson Cancer Center
Peking University People's Hospital
Sun Yat-sen University
Institute of Hematology & Blood Diseases Hospital, China
Washington University School of Medicine
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Columbia University
University of Chicago
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Alabama at Birmingham
Centre Henri Becquerel
Fondazione Italiana Linfomi - ETS
Ruijin Hospital
Peking University People's Hospital
Singapore General Hospital
Nanfang Hospital, Southern Medical University
Shanghai Zhongshan Hospital
Centre Jean Perrin
French Innovative Leukemia Organisation
Assistance Publique - Hôpitaux de Paris
Baylor College of Medicine
University of Rochester
Hadassah Medical Organization
Massachusetts General Hospital
M.D. Anderson Cancer Center
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
City of Hope Medical Center
Yale University
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
Goethe University
Masonic Cancer Center, University of Minnesota
University of Maryland, Baltimore
Stanford University
Tata Memorial Centre
Weill Medical College of Cornell University
First Affiliated Hospital of Zhejiang University
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota